Neogenomics, Inc.
NEO
$7.42
$0.294.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.59M | -78.73M | -77.73M | -78.55M | -84.23M |
| Total Depreciation and Amortization | 72.01M | 72.55M | 72.72M | 72.87M | 73.02M |
| Total Amortization of Deferred Charges | 2.92M | 2.91M | 2.90M | 2.90M | 2.89M |
| Total Other Non-Cash Items | 45.03M | 42.92M | 42.03M | 41.17M | 38.33M |
| Change in Net Operating Assets | -34.76M | -32.63M | -24.92M | -38.13M | -45.18M |
| Cash from Operations | 7.61M | 7.02M | 15.01M | 264.00K | -15.18M |
| Capital Expenditure | -39.98M | -41.06M | -36.52M | -29.99M | -24.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.87M | 53.92M | 72.04M | 89.85M | 91.90M |
| Cash from Investing | 1.89M | 12.86M | 35.52M | 59.85M | 67.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -4.00K | -9.00K | -38.00K |
| Issuance of Common Stock | 7.64M | 7.50M | 7.28M | 7.95M | 6.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.86M | -2.86M | -2.05M | -2.05M | -2.05M |
| Cash from Financing | 4.78M | 4.65M | 5.23M | 5.89M | 3.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.28M | 24.52M | 55.75M | 66.01M | 56.31M |